Consumers are winners in the BRCA gene case
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost ...Read more
Australia | Company results | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2013
Singapore: Australian biopharmaceutical giant CSL has marked sales of $5 billion, achieving a net profit after tax (NPAT...Read more
BioDiem to create new non-influenza vaccines
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement with Th...Read more
Allied to soon get CE mark approval from EU
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...Read more
Researchers create biologically active antibodies
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2012
Singapore: Australian scientists have overcome one of the most pressing problems facing the pharmaceutical industry, how...Read more
Mesoblast CEO: We have $178 mn cash reserves
Australia | Influencers | By Rahul Koul Koul | 3 Comment | 07 Feb, 2013
Australia-based Mesoblast is one-of-the-world's leading developer of innovative biological products in regenerative medi...Read more
Toshiba to distribute Nanosonics trophon EPR in UK
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2013
Singapore: Australia's Nanosonics has signed an agreement with Toshiba Medical Systems and has made Toshiba a non-exclus...Read more
Roche Accu-Chek Combo gets FDA approval
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2012
Singapore: Roche received clearance from the US FDA for its Accu-Chek Combo system for insulin pump therapy. The system ...Read more
Australia pumps in $32.8 mn for diabetes research
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2014
Singapore: The Australian Minister for Education, Mr Christopher Pyne, and Minister for Health, Mr Peter Dutton have ann...Read more
Phosphagenics: Our ex-CEO Esra Ogru stole $5.7 mn
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013
Singapore: Phosphagenics has charged Dr Esra Ogru, its former CEO, of being implicated in the theft of $5.7 million from...Read more
Food allergies may be due to mom's habits during preganacy
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Scientists at the Murdoch Children's Research Institute in Melbourne have established a striking link between...Read more
Hatchtech appoints Hugh Alsop as CEO
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: Specialty pharmaceutical company Hatchtech has appointed former Phosphagenics vice president, Mr Hugh Alsop,...Read more
Garth Tierney is executive VP of INC CRO
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2013
Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible...Read more
Starpharma named Australian company of the year
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2012
Singapore: Starpharma Holdings was named the industry's 2012 Australian company of the year. The Janssen 2012 Industry...Read more
Audeo Oncology announces new board appointments
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: Audeo Oncology, which has offices in Australia and the US, has appointed Ms Leigh Bonney, Dr Susan Kelley and...Read more
Aus gas firm, Queensland univ setup telehealth network
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013
Singapore: The University of Queensland's (UQ) Center for Online Health (COH) and natural gas developer QGC are jointly ...Read more
Medworxx ventures into 'Kangaroo land'
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Apr, 2013
Singapore: Canada-based Medworxx Solutions is expanding into Australia with its partner, EQhealth. Medworxx and EQhealt...Read more
Fondaparinux earns $2 mn profit for Alchemia
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2012
Singapore: Alchemia provided an update on its marketed generic anti-coagulant product, fondaparinux, which was launched...Read more